This guide offers a clear, clinically grounded comparison: what each medication is, how they differ, what the evidence says about their performance, and the specific factors a physician considers when recommending one over the other for a particular patient
Weight loss continues to dominate Americas New Years resolutions, and since 2025, a new category of medications has been driving unprecedented change
This is a good thing in small amounts, but once you develop insulin resistance it becomes a big problem
JAMA Surg 158(10):10031011 Miras AD et al (2019) Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial
Micronized progesterone demonstrates a more favorable cardiometabolic and neurocognitive profile than older synthetic progestins